Narrator: This is Science Today. While there's been some criticism about the war on cancer, which was launched in 1971, the progress that's been made since then has been staggering. Michael Karin, a professor of pharmacology at the University of California, San Diego School of Medicine, who has provided new insight into the connection between inflammation and malignancy, says in terms of increasing our knowledge, the war on cancer has been very successful.
Karin: The important thing about this war on cancer is that the money was not tied to anything specific. It just was really to increase our knowledge. For instance, some of the most important discoveries in basic molecular biology, all the tools that we use in these studies were supported by this type of investment. People doing inflammation research, most of them don't even think of cancer. In the beginning, it was not even obvious that it would be linked to cancer, but progress in inflammation research definitely benefits cancer research and the war on cancer.
Narrator: For Science Today, I'm Larissa Branin.